n-(3-pyrene)maleimide has been researched along with Leukemia, T-Cell in 1 studies
*Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, PC; Chen, CY; Wang, TH; Wang, TV | 1 |
1 other study(ies) available for n-(3-pyrene)maleimide and Leukemia, T-Cell
| Article | Year |
|---|---|
The in vivo anti-leukemia activity of N-(1-Pyrenlyl) maleimide in a bioluminescent mouse model.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Enzyme Inhibitors; Fluorescent Dyes; Humans; Jurkat Cells; Leukemia, T-Cell; Luminescent Measurements; Maleimides; Mice; Mice, Nude; Telomerase; Xenograft Model Antitumor Assays | 2017 |